Suppr超能文献

吸入吗啡对慢性肺病患者运动时呼吸困难发展的影响。

Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.

作者信息

Leung R, Hill P, Burdon J

机构信息

Department of Respiratory Medicine, St Vincent's Hospital, Victoria, Australia.

出版信息

Thorax. 1996 Jun;51(6):596-600. doi: 10.1136/thx.51.6.596.

Abstract

BACKGROUND

Inhaled morphine has previously been shown to increase exercise endurance in patients with chronic lung disease. A similar study was performed to determine whether inhaled morphine reduces the sensation of breathlessness in this group of patients.

METHODS

A randomised double blind study on the effect of nebulised morphine on both exercise induced breathlessness and maximum achievable power output using isotonic saline as a control was performed in 10 patients with stable chronic lung disease. Each subject performed a progressive exercise test (Jones' stage I) on an electrically braked cycle ergometer. The work load was increased by 10 watts per minute and subjects exercised to exhaustion. At the end of each minute of exercise patients were asked to rate their degree of breathlessness according to a modified Borg scale. All subjects were randomised to receive either inhaled morphine sulphate 1 mg/ml (5 ml) or isotonic saline (5 ml) by wet nebulisation. The effect of morphine and saline on the achieved exercise capacity and the development of breathlessness during exercise was tested on separate days.

RESULTS

The mean dose of morphine inhaled was 1.24 mg. There was no difference in maximum power output achieved, minute ventilation at maximum power output, nor the degree of breathlessness at maximum power output between the groups treated with morphine and placebo. The degree of breathlessness was related to the power output achieved during exercise by a power function relationship (mean r: morphine = 0.86, saline = 0.87). However, there was a wide variation in the sensation for any given power output in both groups. There was no difference in the group mean slopes (morphine = 1.15, saline = 1.00) or intercepts (morphine = 0.07, saline = 0.15) in this relationship between the morphine and saline treatment groups.

CONCLUSIONS

In patients with severe chronic lung disease inhaled morphine in the doses used in this study does not relieve exercise induced breathlessness nor does it increase maximum power output achieved during progressive exercise.

摘要

背景

此前已有研究表明,吸入吗啡可提高慢性肺病患者的运动耐力。本研究旨在确定吸入吗啡是否能减轻该组患者的呼吸急促感。

方法

对10例稳定期慢性肺病患者进行了一项随机双盲研究,以雾化吗啡对运动诱发的呼吸急促和使用等渗盐水作为对照的最大可实现功率输出的影响。每位受试者在电动制动的自行车测力计上进行渐进性运动试验(琼斯I期)。工作量每分钟增加10瓦,受试者运动至疲惫。在运动的每分钟末,要求患者根据改良的博格量表对其呼吸急促程度进行评分。所有受试者随机接受雾化吸入1mg/ml硫酸吗啡(5ml)或等渗盐水(5ml)。分别在不同日期测试吗啡和盐水对运动能力和运动过程中呼吸急促发展的影响。

结果

吸入吗啡的平均剂量为1.24mg。在接受吗啡治疗和安慰剂治疗的组之间,最大输出功率、最大功率输出时的分钟通气量以及最大功率输出时的呼吸急促程度均无差异。呼吸急促程度与运动过程中通过幂函数关系实现的功率输出相关(平均r:吗啡=0.86,盐水=0.87)。然而,两组中任何给定功率输出的感觉存在很大差异。吗啡和盐水治疗组之间在这种关系中的组平均斜率(吗啡=1.15,盐水=1.00)或截距(吗啡=0.07,盐水=0.15)没有差异。

结论

在本研究使用的剂量下,吸入吗啡并不能缓解重度慢性肺病患者运动诱发的呼吸急促,也不会增加渐进性运动过程中实现的最大输出功率。

相似文献

引用本文的文献

1
IPF Respiratory Symptoms Management - Current Evidence.特发性肺纤维化的呼吸症状管理——当前证据
Front Med (Lausanne). 2022 Jul 28;9:917973. doi: 10.3389/fmed.2022.917973. eCollection 2022.
6
Does nebulized fentanyl relieve dyspnea during exercise in healthy man?雾化芬太尼能否缓解健康男性运动期间的呼吸困难?
J Appl Physiol (1985). 2015 Jun 1;118(11):1406-14. doi: 10.1152/japplphysiol.01091.2014. Epub 2015 Mar 12.
8
The management of dyspnea in cancer patients: a systematic review.癌症患者呼吸困难的管理:一项系统综述
Support Care Cancer. 2008 Apr;16(4):329-37. doi: 10.1007/s00520-007-0389-6. Epub 2008 Jan 24.
9
Palliative management of refractory dyspnea in COPD.慢性阻塞性肺疾病难治性呼吸困难的姑息治疗
Int J Chron Obstruct Pulmon Dis. 2006;1(3):289-304. doi: 10.2147/copd.2006.1.3.289.

本文引用的文献

9
Dihydrocodeine for breathlessness in "pink puffers".二氢可待因用于“粉红吹笛者”的呼吸困难
Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):675-7. doi: 10.1136/bmj.286.6366.675.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验